ipo cyteir therapeutics ekonomicheskaja model 4e2d255 IPO Cyteir Therapeutics (экономическая модель) 2

IPO Cyteir Therapeutics (economic model)

Ticker: CYT

Develops small molecule therapies, which inhibit the repair of DNA damage.

Revenue

Missing

Profit

While losses

Express withdrawal

A classic pharmaceutical company with a potential drug discovery.

Debts

0,1 debt / equity, at a rate of less than 2

Excellent indicator

Financial calculation

There is nothing to evaluate without revenue.

There is no fair share price.

IPO range: $16 -18.

I do not participate, because. the company has no revenue.

  AuthID.ai biometric platform revised uplisting conditions on Nasdaq
Scroll to Top